Biosimilars: Infliximab IV, Tocilizumab IV en SC, Denosumab SC en Epoëtine alfa
- Buyer
- IMELDA VZW
- Published
- 2026-11-02
- Deadline
- 2026-12-01T09:00:00+00:00
- Sources
- TED
- Value
- Not provided
Description
The description is in the source language.
Biosimilars: Infliximab IV, Tocilizumab IV en SC, Denosumab SC en Epoëtine alfa
CPV: 33690000
Membership
Read notice previews free of charge. Official notice and document links, construction permits and personal MCP access require an active paid membership.
Read